BECTON, DICKINSON AND COMPANY Accrued Liabilities, Current
BECTON, DICKINSON AND COMPANY (BDX) had Accrued Liabilities, Current of $3.10 billion as of 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2025-11-25
- 2025-09-30: Accrued Liabilities, Current $3.10B.
- 2024-09-30: Accrued Liabilities, Current $3.48B.
- 2023-09-30: Accrued Liabilities, Current $2.60B.
- 2022-09-30: Accrued Liabilities, Current $2.60B.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2025-09-30 | $3.10B 10-K · filed 2025-11-25 | |
| 2024-09-30 | $3.48B 10-K · filed 2025-11-25 | |
| 2023-09-30 | $2.60B 10-K · filed 2024-11-27 | |
| 2022-09-30 | $2.60B 10-K · filed 2023-11-21 | |
| 2021-09-30 | $2.87B 10-K · filed 2022-11-22 | $2.94B 10-K · filed 2021-11-24 |
| 2020-09-30 | $2.64B 10-K · filed 2021-11-24 | |
| 2019-09-30 | $2.13B 10-K · filed 2020-11-25 | |
| 2018-09-30 | $2.25B 10-K · filed 2019-11-27 | |
| 2017-09-30 | $1.39B 10-K · filed 2018-11-21 | |
| 2016-09-30 | $1.57B 10-K · filed 2017-11-22 | |
| 2015-09-30 | $1.62B 10-K · filed 2016-11-23 | |
| 2014-09-30 | $1.05B 10-K · filed 2015-11-25 | |
| 2013-09-30 | $1.07B 8-K · filed 2015-03-13 | |
| 2012-09-30 | $741.00M 10-K · filed 2013-11-27 | $740.64M 10-K · filed 2012-11-21 |
| 2011-09-30 | $795.22M 10-K · filed 2012-11-21 | |
| 2010-09-30 | $661.11M 10-K · filed 2011-11-23 | |
| 2009-09-30 | $646.54M 10-K · filed 2010-11-24 | |
| 2008-09-30 | $519.12M 10-K/A · filed 2010-01-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |